Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

lentiCas9n(D10A)-Blast Citations (3)

Originally described in: Improved vectors and genome-wide libraries for CRISPR screening.
Sanjana NE, Shalem O, Zhang F Nat Methods. 2014 Aug;11(8):783-4. doi: 10.1038/nmeth.3047.
PubMed Journal

Articles Citing lentiCas9n(D10A)-Blast

Articles
Biallelic mutations in human NHLRC2 enhance myofibroblast differentiation in FINCA disease. Paakkola T, Salokas K, Miinalainen I, Lehtonen S, Manninen A, Kaakinen M, Ruddock LW, Varjosalo M, Kaarteenaho R, Uusimaa J, Hinttala R. Hum Mol Genet. 2018 Dec 15;27(24):4288-4302. doi: 10.1093/hmg/ddy298. PubMed
Advanced single-cell pooled CRISPR screening identifies C19orf53 required for cell proliferation based on mTORC1 regulators. Tang Y, Liao S, Liu G, Xiong X, Liu H, Li F, Tan Z, Kong X, Yin Y, Tan B. Cell Biol Toxicol. 2021 Feb 13. pii: 10.1007/s10565-021-09586-0. doi: 10.1007/s10565-021-09586-0. PubMed
Topoisomerase IIalpha represses transcription by enforcing promoter-proximal pausing. Herrero-Ruiz A, Martinez-Garcia PM, Terron-Bautista J, Millan-Zambrano G, Lieberman JA, Jimeno-Gonzalez S, Cortes-Ledesma F. Cell Rep. 2021 Apr 13;35(2):108977. doi: 10.1016/j.celrep.2021.108977. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.